IceCure Medical (ICCM) Long-Term Deferred Tax (2020 - 2022)

IceCure Medical (ICCM) has 3 years of Long-Term Deferred Tax data on file, last reported at $17.3 million in Q4 2022.

• Quarterly Long-Term Deferred Tax rose 21.84% year-over-year to $17.3 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $17.3 million (up 21.84% YoY) and the FY2022 annual result came in at $17.3 million, up 21.84% from the prior year.
• Long-Term Deferred Tax rose to $17.3 million in Q4 2022 per ICCM's latest filing, from $14.2 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $17.3 million in Q4 2022 and bottomed at $12.0 million in Q4 2020.
• The 3-year median for Long-Term Deferred Tax is $14.2 million (2021), against an average of $14.5 million.
• The widest annual swing landed in 2021, when Long-Term Deferred Tax rose 17.94%; it then grew 21.84% in 2022.
• Tracing ICCM's Long-Term Deferred Tax over 3 years: stood at $12.0 million in 2020, then increased by 17.94% to $14.2 million in 2021, then advanced by 21.84% to $17.3 million in 2022.
• Per Business Quant, the three latest ICCM Long-Term Deferred Tax figures stand at $17.3 million (Q4 2022), $14.2 million (Q4 2021), and $12.0 million (Q4 2020).

Peer Comparison